Table 5.
Observed and Expected Numbers of Symmetrical Class 2 Domains in the Human Genome
| Category | Comb. | Obs. | Exp. | P |
| 2 exon domains | ||||
| Domain (367) | 0–0 | 31 | 16.1 | <0.02 |
| 1–1 | 194 | 156.9 | <10−4 | |
| 2–2 | 10 | 7.4 | 0.33 | |
|
235 | 180.4 | <10−7 | |
| Domain family (74) | 0–0 | 10.6 | 8.6 | 0.47 |
| 1–1 | 21.5 | 14.6 | <0.05 | |
| 2–2 | 2.8 | 3.4 | n.d. | |
|
34.9 | 26.6 | <0.05 | |
| 3 exon domains | ||||
| Domain (155) | 0–0 | 23 | 18.1 | 0.22 |
| 1–1 | 50 | 38.5 | <0.05 | |
| 2–2 | 6 | 3.8 | n.d. | |
|
79 | 60.4 | <0.01 | |
| Domain family (63) | 0–0 | 12.7 | 11.7 | 0.75 |
| 1–1 | 12.3 | 8.3 | 0.14 | |
| 2–2 | 3.5 | 2.6 | n.d. | |
|
28.5 | 22.5 | 0.12 | |
| 4 exon domains | ||||
| Domain (115) | 0–0 | 24 | 18.9 | 0.2 |
| 1–1 | 33 | 20.9 | <10−3 | |
| 2–2 | 3 | 3 | n.d. | |
|
60 | 42.8 | <10−3 | |
| Domain family (49) | 0–0 | 10.1 | 9.6 | 0.86 |
| 1–1 | 9.5 | 5.9 | 0.11 | |
| 2–2 | 1 | 0.6 | n.d. | |
|
20.6 | 16.1 | 0.17 | |
| 5 exon domains | ||||
| Domain (70) | 0–0 | 25 | 22.8 | 0.57 |
| 1–1 | 5 | 2.7 | n.d. | |
| 2–2 | 0 | 1.9 | n.d. | |
|
30 | 27.4 | 0.52 | |
| Domain family (39) | 0–0 | 15 | 12.4 | 0.37 |
| 1–1 | 3.5 | 1.9 | n.d. | |
| 2–2 | 0 | 1 | n.d. | |
|
18.5 | 14.3 | 0.16 | |
| 6 exon domains | ||||
| Domain (75) | 0–0 | 27 | 22.8 | 0.29 |
| 1–1 | 6 | 4.3 | n.d. | |
| 2–2 | 3 | 3.1 | n.d. | |
|
36 | 30.2 | 0.17 | |
| Domain family (43) | 0–0 | 16.7 | 14.6 | 0.5 |
| 1–1 | 2.7 | 2 | n.d. | |
| 2–2 | 2.3 | 1.6 | n.d. | |
|
21.7 | 18.2 | 0.28 |
-
↵Total numbers of domains and families in each category are indicated in parentheses. Summed symmetrical combinations are shown in boldface. The expected values were calculated based on the frequencies of flanking intron phases. (Comb.) Combinations; (Obs.) observed; (Exp.) expected.











